Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8329 - 8336 of 12008 results
Massachusetts Senate Passes 3 Higher Education Bills
March 30, 2016| Blog| Viewpoint
Paul Dickerson and Tom Burton Emphasize the Importance of Energy Diversity Amidst a Changing Global Energy Landscape
March 29, 2016| Blog| Viewpoint
Summer Blockbuster: DOL’s Divisive Union “Persuader” Rule Coming to Employers Near You on July 1, 2016
March 29, 2016| Blog| Viewpoint
Four Reasons to File an RCE with a Request to Suspend Processing
March 29, 2016| Blog| Viewpoint
CMS Seeks Input on Medicare's Value-Based Insurance Design Model
March 29, 2016| Blog| Viewpoint
Post-Senate Vote, Major Food Manufacturers Choose to Label Genetically Engineered Foods
March 29, 2016| Blog| Viewpoint
Supreme Court Decides to Hear Samsung v. Apple, Appears Ready to Weigh-In on Patent Damage Calculations
March 28, 2016| Blog| Viewpoint
USCIS Guidance on "Same or a Similar" Occupation for AC21 Welcomed
March 28, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|